Xopenex and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xopenex (levalbuterol hydrochloride) and Atacand (candesartan cilexetil). Common drug interactions include oesophageal stenosis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Xopenex and Atacand. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

40 people who take Xopenex and Atacand together, and have interactions are studied.

Xopenex and Atacand drug interactions.

What are the common drug interactions of Xopenex and Atacand, by gender? *:

female:

  1. Oesophageal stenosis (narrowing of oesophagus)
  2. Oral candidiasis (fungal infection of mouth)
  3. Osteoporosis (bones weak and more likely to break)
  4. Pericardial effusion (fluid around the heart)
  5. Pleural effusion (water on the lungs)
  6. Pulmonary granuloma (tiny lump of inflamed tissue in the lungs)
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Pyrexia (fever)
  9. Red blood cell count decreased
  10. Renal failure chronic (long lasting kidney dysfunction)

male:

  1. Pneumonia
  2. Blood cholesterol increased
  3. Arthropathy
  4. Bacterial infection
  5. Blood creatine phosphokinase increased
  6. Blood glucose increased
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Cluster headache (one-sided head pain with tearing)
  10. Cough

What are the common drug interactions of Xopenex and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Kyphoscoliosis (abnormal curving of the spine)
  2. Libido decreased (loss of interest in sex)
  3. Lipoma (a growth of fatty tissue that slowly develops just under your skin)
  4. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  5. Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
  6. Migraine (headache)
  7. Myalgia (muscle pain)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Nausea (feeling of having an urge to vomit)
  10. Neck pain

60+:

  1. Pneumonia
  2. Muscle spasms (muscle contraction)
  3. Lymphocyte count decreased
  4. Mass
  5. Swelling
  6. Anaemia (lack of blood)
  7. Dyspnoea (difficult or laboured respiration)
  8. Abdominal discomfort
  9. Arthralgia (joint pain)
  10. Collapse of lung (functional breakdown of lung)

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 10 people, 25.00%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 10.00%
  3. Pain: 4 people, 10.00%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 10.00%
  5. Nausea (feeling of having an urge to vomit): 4 people, 10.00%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 10.00%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.50%
  8. Stress And Anxiety: 3 people, 7.50%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.50%
  10. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xopenex and Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol hydrochloride and candesartan cilexetil (the active ingredients of Xopenex and Atacand, respectively), and Xopenex and Atacand (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: